Acme United Q3 net sales rise 18% to $58.0 million; diluted EPS $0.80
Acme United reported third-quarter 2026 net sales of $58.0 million, up 18% from $49.1 million a year earlier, with comparable sales up 10% excluding My Medic. Net income rose to $3.4 million, or $0.80 per diluted share, from $1.9 million, or $0.46, helped by a $4.0 million recognized tariff refund that was partly offset by $1.8 million of DMT facility closure costs. Shareholders get a quarter of higher sales and profit, though the company said My Medic's earnings contribution is seasonal and concentrated in the fourth quarter.
Key points
- Q3 net sales $58.0 million vs. $49.1 million, up 18%; comparable sales up 10% excluding My Medic
- Q3 net income $3.4 million, or $0.80 diluted EPS, vs. $1.9 million, or $0.46 a year earlier
- Gross margin 45.3% vs. 39.1%, including a benefit of approximately 690 basis points from the tariff refund
- Company plans to close its DMT plant in Massachusetts later this year, with annual savings expected to exceed $1.0 million in 2027
The filing
Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.